Clinical Trial Update: Early Neutropenic Fever De-escalation of Antibiotics Study [Phase 3]

View source ↗

Summary

Phase 3 trial exploring de-escalation of antibiotics for early neutropenic fever in hematologic malignancy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia
• Hematologic Malignancy

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Hematologic Malignancy, Febrile Neutropenia | Phase 3 | Status: NOT_YET_RECRUITING